ArticleFrontiers in pharmacology2022

Naringenin is a Potential Anabolic Treatment for Bone Loss by Modulating Osteogenesis, Osteoclastogenesis, and Macrophage Polarization.

Xin Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.